Exploring the antioxidant potential of Moringa oleifera leaf extracts mitigating doxorubicin-induced cardiotoxicity in male rats

Exploring the antioxidant potential of Moringa oleifera leaf extracts mitigating doxorubicin-induced cardiotoxicity in male rats

Doxorubicin (DOX) is a commonly used drug in chemotherapy for cancer treatment. However, it can cause the threatening side effect of cardiotoxicity. This study investigates whether the hydro-alcoholic leaves of have any protective potential against DOX-induced cardiotoxicity. The phytochemical analy...

Full description

Saved in:
Bibliographic Details
Published in:Journal of advanced pharmaceutical technology and research Vol. 15; no. 3; pp. 166 - 170
Main Authors: Obeid, Ruaa Ali, Mohammed, Rusul Ahmed, Kaskoos, Raad A, Zair, Amira
Format: Journal Article
Language:English
Published: India Medknow Publications & Media Pvt. Ltd 01-07-2024
Wolters Kluwer - Medknow
Wolters Kluwer Medknow Publications
Subjects:
antioxidant
Antioxidants
Bioactive compounds
Cancer therapies
Cardiomyocytes
Cardiotoxicity
Chemotherapy
Doxorubicin
Interleukin 6
Lipid peroxidation
Moringa oleifera
Original
Oxidative stress
phytochemicals
Plant extracts
Troponin I
cardiotoxicity
phytochemicals
Moringa oleifera
Antioxidant
oxidative stress
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
Description
Summary:Doxorubicin (DOX) is a commonly used drug in chemotherapy for cancer treatment. However, it can cause the threatening side effect of cardiotoxicity. This study investigates whether the hydro-alcoholic leaves of have any protective potential against DOX-induced cardiotoxicity. The phytochemical analysis showed that the plant extracts contained bioactive compounds with antioxidant activities. The DOX-treated group confirmed a significant increment in cardiac troponin I (cTnI) and proinflammatory cytokine interleukin-6 (IL-6) levels, which indicates damage to the cardiomyocytes and also inflammation. However, treatment with the extracts significantly inhibited DOX-induced cardiomyocyte damage, as indicated by the significantly low cTnI release. Furthermore, treatment with extracts further increased antioxidant activities, thereby decreasing oxidative stress and lipid peroxidation. Moreover, DOX was found to increase the IL-6 level, and treatment with extracts had a significant impact on the inhibition of IL-6 levels. These results indicate that the extracts have a cardioprotective effect and can play a role as an adjunct drug in mitigating DOX-induced cardiotoxicity, thus providing new prospects for the improvement of safety and efficacy in the treatment of cancer.
Bibliography:ObjectType-Article-1
SourceType-Scholarly Journals-1
ObjectType-Feature-2
content type line 23
ISSN:2231-4040
0976-2094
DOI:10.4103/JAPTR.JAPTR_531_23